Name: INSP Income Statement - Inspire Medical Systems Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

INSP - Inspire Medical Systems, Inc.

USD | NYSE | Healthcare

INSP Income Statement - Inspire Medical Systems Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17
Revenues
Revenues	204.6	269.1	224.5	217.1	201.3	239.7	203.2	195.9	164.0	192.5	153.3	151.1	127.9	137.9	109.2	91.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenues
Revenues	915.2	912.0	802.8	624.8	407.9	233.4	115.4	82.1	50.6	28.6
Cost of Revenue	130.2	133.2	123.0	96.6	66.1	33.3	17.6	13.6	10.1	6.0
Gross Profit	785.1	778.8	679.8	528.2	341.7	200.1	97.8	68.4	40.5	22.5
Operating Expenses
Research & Development	101.2	103.2	114.1	116.5	68.6	37.4	26.1	12.8	7.4	6.2
Selling General & Administrative	632.6	624.6	529.6
Operating Income
Operating Income	51.3	51.0	36.1	(40.3)	(47.6)	(39.9)	(56.2)	(34.9)	(20.4)	(16.0)
Non-Operating
Interest Income	16.2	17.5	23.2	20.6	5.1	0.1	1.1	3.8	1.9	0.2
Interest Expense	-	0.1	0.0	0.0
Tax & Net
Income Tax Expense	(67.2)	(79.7)	4.9	1.2	0.6	0.1	0.1	0.0	0.0	0.0
Net Income From Continuing Ops	131.1	145.4	53.5
Per Share
EPS Basic	4.57	4.95	1.80	(0.72)	(1.60)	(1.54)	(2.19)	(1.40)	-	-
EPS Diluted	4.57	4.89	1.75	(0.72)
Supplementary Data
EBITDA	67.3	64.9	42.6	(37.4)	(45.7)	(38.6)	(55.4)	(34.4)	(20.0)	(15.7)
EBIT	51.3	51.0	36.1	(40.3)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	25.8	24.9	24.2	26.2	27.8	30.3	26.1	28.9	28.9	31.1	29.1	30.8	25.5	21.2	21.0	14.5	11.9	10.3	9.6	9.3	8.2	7.3	7.3	6.1	5.4	3.8	3.6	2.8	2.6	2.2	1.8	1.7	1.7	1.7	1.2	1.7	1.6
Selling General & Administrative	152.2	162.0	158.9	159.5	144.3	141.5	130.4	132.1	125.6	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	130.4	132.1	125.6	-	113.2	112.6	102.0	-	85.6	76.7	63.6
Depreciation & Amortization	5.1	3.8	3.7	3.4	3.0	2.4	1.9	1.4	0.8	0.8	0.8	0.7	0.6	0.6	0.5	0.4
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	156.5	160.9	154.5	155.2	142.4	143.4	127.5	116.1	106.6	91.2

Operating Income
Operating Income	(1.1)	46.1	9.6	(3.3)	(1.5)	31.9	14.3	5.1	(15.2)	9.3	(13.5)	(16.6)	(19.5)	(0.3)	(17.2)	(14.0)	(16.1)	(1.8)	(9.8)	(12.5)	(15.7)	(7.1)	(9.9)	(22.8)	(16.4)	(9.3)	(8.7)	(8.2)	(8.8)	(4.9)	(4.6)	(5.6)	(5.2)	(3.8)	(3.6)	(4.4)	(4.1)

Tax & Net
Income Tax Expense	13.7	(85.8)	3.6	1.3	1.2	1.4	1.8	1.1	0.7	0.5	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	-	-
Net Income From Continuing Ops	(11.3)	136.1	9.9	(3.6)	3.0	35.2	18.5	9.8	(10.0)	14.8	(8.5)	(12.0)	(15.4)	3.2	(16.8)	(14.5)	(16.7)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(11.3)	136.1	9.9	(3.6)	3.0	35.2	18.5	9.8	(10.0)	14.8	(8.5)	(12.0)	(15.4)	3.2	(16.8)	(14.5)	(16.7)
Net Income Attributable To Parent	(11.3)	136.1	9.9	(3.6)	3.0	35.2	18.5	9.8	(10.0)	14.8	(8.5)	(12.0)	(15.4)	3.2	(16.8)	(14.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(11.3)	136.1	9.9	(3.6)	3.0	35.2	18.5	9.8	(10.0)	14.8	(8.5)	(12.0)	(15.4)	3.2	(16.8)

Per Share
EPS Basic	(0.39)	-	0.34	(0.12)	0.10	-	0.62	0.33	(0.34)	-	(0.29)	(0.41)	(0.53)	-	(0.60)	(0.53)	(0.61)	-	(0.38)	(0.48)	(0.60)	-	(0.39)	(0.88)	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	(0.39)	-	0.34	(0.12)	0.10	-	0.60	0.32	(0.34)	-	(0.29)	(0.41)	(0.53)	-	(0.60)	(0.53)	(0.61)	-
Shares Basic	28.7	-	29.3	29.5	29.7	-	29.9	29.7	29.6	-	29.4	29.2	29.1	-	28.2	27.6	27.5	-
Shares Diluted	28.7	-	29.6	29.5	30.3	-	30.6	30.4	29.6	-	29.4	29.2	29.1	-	28.2	27.6	27.5	-

Supplementary Data
EBITDA	4.0	49.9	13.3	0.1	1.6	34.3	16.2	6.5	(14.4)	10.1	(12.7)	(15.9)	(18.9)	0.3	(16.7)	(13.6)	(15.7)	(1.4)	(9.5)	(12.2)	(15.5)	(6.8)	(9.7)	(22.6)	(16.3)	(9.1)	(8.6)	(8.1)	(8.7)	(4.8)	(4.5)	(5.5)	(5.1)	(3.8)	(3.5)	(4.3)	(4.1)
EBIT	(1.1)	46.1	9.6	(3.3)	(1.5)	31.9	14.3	5.1	(15.2)	9.3	(13.5)	(16.6)	(19.5)	(0.3)	(17.2)	(14.0)	(16.1)	(1.8)	(9.8)